Tuesday - December 23, 2025
CAMP4 Therapeutics Enters GSK Collaboration to Advance RNA-Based Therapies
December 22, 2025
BOSTON, Massachusetts, Dec. 22 [Category: BizLaw/Legal] -- Ropes and Gray, a law firm, issued the following news:

* * *

CAMP4 Therapeutics Enters GSK Collaboration to Advance RNA-Based Therapies

*

Ropes & Gray advised CAMP4 Therapeutics in a strategic research, collaboration and license agreement with GSK to identify and develop antisense oligonucleotide (ASO) drug candidates for multiple gene targets for neurodegenerative and kidney diseas . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products